Ledger.Open graph →
SEC Form D · Amendment · filed September 4, 2020

IN8BIO, INC

Offering
$35.0M
Sold
$35.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Thomas Cirrito · New York, NYDirectorLarry Lamb · New York, NYExecPeter Brandt · New York, NYDirectorTravis Whitfill · Farmington, CTDirectorMelissa Beelen · New York, NYExecWilliam Ho · New York, NYExec · DirectorTravis Whitfill · Farmington, CTDirectorMelissa Beelen · New York, NYExecThomas Cirrito · New York, NYDirectorLarry Lamb · New York, NYExecWilliam Ho · New York, NYExec · DirectorPeter Brandt · Colorado Springs, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗